Implementation of In-Clinic SARS-CoV-2 Vaccination in Advanced Heart Failure, Lung Disease, and Transplant Clinic

PURPOSE: Vaccine hesitancy is a hurdle to achieving full vaccination against SARS-CoV-2 in the U.S. In an effort to address vaccine hesitancy among the high-risk group of advanced heart and lung disease and post-heart and lung transplant patients, we implemented an in-clinic vaccination program. Sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathai, S.K., Cink, C., Talamayan, L., Peattie, J., Africa, Y., Dunn, S., Peterson, T., Rosenblatt, R.L., Grazia, T.J., Sam, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(1051)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988597/
http://dx.doi.org/10.1016/j.healun.2022.01.1072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988597/
http://dx.doi.org/10.1016/j.healun.2022.01.1072

Ejemplares similares